Case Reports in the Age of Twitter von Cifu, Adam S., Vandross, Andrae L., Prasad, Vinay

Volltext

Abstract A050: A Phase 1 dose escalation study of TACH101, a first-in-class KDM4 inhibitor for advanced solid tumors von Tsimberidou, Apostolia, Vandross, Andrae L, Sommerhalder, David, Joseph, Charmaine, Chandhasin, Chandtip, Perabo, Frank, Clarke, Michael F

Volltext

Abstract LB_A25: Updated Phase 1 results from the PYNNACLE Phase 1/2 study of PC14586, a selective p53 reactivator, in patients with advanced solid tumors harboring a  TP53   Y220C... von Schram, Alison M, Shapiro, Geoffrey I, Johnson, Melissa L, Tolcher, Anthony W., Thompson, John A, El-Khoueiry, Anthony B, Vandross, Andrae L, Kummar, Shivaani, Parikh, Aparna R, Shepard, Dale R, Garczarek, Ursula, LeDuke, Kim, Sheehan, Lisa, Fellous, Marc, Alland, Leila, Dumbrava, Ecaterina E

Volltext

A phase 1/2 study of DCC-3116 as a single agent and in combination with trametinib in patients with advanced or metastatic solid tumors with RAS or RAF mutations von Tolcher, Anthony W., Hong, David S., Vandross, Andrae Lavon, Psoinos, Charles M, Brennan, Denise Marie, Sherman, Matthew L., Ruiz-Soto, Rodrigo, Reu, Frederic J., Weekes, Colin D.

Volltext